Well to keep is kosher, I apologize if anybody got the idea I was anti Semitic, just so were clear I've plenty of Jew friends and colleagues. Back to subject of owcp now, you said GWPH was $8 was in 2013, and now trading $120+ that's also with a ground breaking treatment for multiple sclerosis. What's going to make Owcp product for psoriasis so ground breaking? The psoriasis industry by 2020 is going to be over $7.4B. What I want to know is what is going to make Owcp product captalize on market share when there are already cbd oils out there in the market? That's is what fund managers have taken a closer look at lately and they see the mj rush is over. That's why Owcp ran. There have been no revenues yet. What's going to make this move are the lymphoma myeloma products. As for now, Owcp HAS to pass efficacy results, and that's why I say I trust israel, because if owcp doesn't pass, they'll already be late to the game and the market will be saturated. Lets not all think just because the says cbd on the tube massive revenues are going to be made. For a company with no revenues, we're lucky to have the market cap we do.